Evidence map›Paper›PMID 41826473›Full record

ReviewAdvances in biochemical engineering/biotechnology2026

Alternative Strategies to Promote Biomolecule Nucleation.

Jose A Gavira, Abel Moreno

Abstract readReview
PubMed Publisher
In one paragraph

Review in Advances in biochemical engineering/biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Jose A GaviraLaboratorio de Estudios Cristalográficos, Instituto Andaluz de Ciencias de la Tierra, CSIC, Armilla, Granada, Spain. j.gavira@csic.es.ORCID https://orcid.org/0000-0002-7386-6484
Abel MorenoLaboratorio de Química de Biomacromoléculas 5, Instituto de Química, Universidad Nacional Autónoma de México, Ciudad Universitaria, Ciudad de México, Mexico.ORCID https://orcid.org/0000-0002-5810-078X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nucleation marks the beginning of phase separation in a system driven to produce crystalline material. Therefore, to determine the final characteristics of the product, crystal density, and size, nucleation should be fine-tuned. This is a general behavior, independent of the nature of the substance. In protein crystallization, the primary goal is typically to obtain crystals of the highest quality possible for structure determination and of a size suitable for the technique to be used. Small homogeneous crystals are queried for XFEL and serial crystallography, whereas neutron diffraction requires them to be cubic millimeter-sized, and electron diffraction needs flat micrometer-sized samples. Therefore, understanding how nucleation occurs and controlling it are of paramount importance not only for crystallizing target enzymes but also for producing biomolecule crystals for pharmaceutical and industrial applications. There are numerous possibilities and strategies for inducing nucleation in protein crystallization, based on various characteristics such as chemical influences, modified surfaces, or physical methods, including the use of external fields, e.g., electric, magnetic, ultrasound, or light. In this chapter, we will cover a portion of these possibilities. We will review the influence of several chemical substances, including hydrogels, modified surfaces, nanoparticles, and ionic liquids. New trends, such as the use of the switchable water concept and crystallization under hydrophobic conditions, will also be introduced as future perspectives.

Indexed as

HydrogelsNanoparticlesProteinsCrystallizationPhase SeparationHydrogelsProteinsBiomacromolecule crystallizationHeterogeneous nucleationNucleation

Identifiers

PMID41826473

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.